InDevR Overview

  • Founded
  • 2003
Founded
  • Status
  • Private
  • Employees
  • 44
Employees
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 5

InDevR General Information

Description

Provider of progressive analytical technologies intended to enhance and accelerate characterization and production of vaccines and other biologics. The company's technologies develop next-generation diagnostic products to facilitate unprecedented tracking of seasonal and emerging influenza viruses around the globe as well as offers a range of other microarray-related products such as viral vaccines, conjugate vaccines, mRNA vaccines, cell and gene therapy as well as therapeutic antibodies and provides testing and customized services, thereby helping clients in their vaccine research, development and manufacturing.

Contact Information

Website
www.indevr.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Primary Office
  • 2100 Central Avenue
  • Suite 106
  • Boulder, CO 80301
  • United States
+1 (303) 000-0000

InDevR Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

InDevR Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Debt - PPP 01-May-2020 000 Completed Generating Revenue
5. Later Stage VC (Series A) 10-Sep-2019 000 000 000.00 Completed Generating Revenue
4. Grant 08-Nov-2018 Completed Generating Revenue
3. Grant 00.00 Completed Generating Revenue
2. Grant 01-Jan-2016 $5.91M Completed Generating Revenue
1. Grant 01-Jan-2004 $9M Completed Generating Revenue
To view InDevR’s complete valuation and funding history, request access »

InDevR Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.0 00.0 00.0 00 00.0 00.000
To view InDevR’s complete cap table history, request access »

InDevR Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of progressive analytical technologies intended to enhance and accelerate characterization and production of va
Biotechnology
Boulder, CO
44 As of 2021
000
000000000 - 000

000000 0

amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqu
0000000000 000000000
Frederick, MD
00 As of 0000
000.00
000000000 - 000.00

00000000

giat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deser
0000000000 000000000
Newark, CA
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InDevR Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Akonni Biosystems Venture Capital-Backed Frederick, MD 00 000.00 000000000 - 000.00
00000000 000000000 Formerly VC-backed Newark, CA 000000&0
000000 00000000 Venture Capital-Backed Williamsville, NY 00 00.000 000000000 - 00.000
000 000 0000000000 Formerly PE-Backed Saclay, France 000 000000000000
0000000 0000000000 Corporate Backed or Acquired Carlsbad, CA 000 0000 000000&0 0000
You’re viewing 5 of 13 competitors. Get the full list »

InDevR Executive Team (6)

Name Title Board Seat Contact Info
Kathy Rowlen Ph.D Co-Founder, Board Member, Chief Executive Officer & Chief Scientific Officer
Shannon Rodriguez Chief Operating Officer & Board Member
Erica Dawson Ph.D Chief Technical Officer
Terry Salyer Chief Commercial Officer
John Birks Ph.D Executive Vice President & Co-Founder
You’re viewing 5 of 6 executive team members. Get the full list »

InDevR Board Members (4)

Name Representing Role Since
Barry Buckland Ph.D InDevR Board Member 000 0000
Glenn Rockman Self Board Member 000 0000
Michael Chang InDevR Board Member 000 0000
Shannon Rodriguez InDevR Chief Operating Officer & Board Member 000 0000
To view InDevR’s complete board members history, request access »

InDevR Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InDevR Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Adjuvant Capital Impact Investing Minority 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Defense Advanced Research Projects Agency Government 000 0000 000000 0
To view InDevR’s complete investors history, request access »

InDevR Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 10-Apr-2013 00000 00000 00 00.00 Biotechnology 00000 000000 00.0
To view InDevR’s complete investments history, request access »

InDevR Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 10-Apr-2013 00000 00000 00 00.00 Completed
  • 3 buyers
To view InDevR’s complete exits history, request access »